title: Reperfusion therapy for acute ischemic stroke: how should we react to the Third Interventional Management of Stroke (IMS III) trial?
authors.affiliation: Department of Neurology, Mayo Clinic, Jacksonville, FL.
authors.forename: James F
authors.initials: JF
authors.lastname: Meschia
authors.forename: Kevin M
authors.initials: KM
authors.lastname: Barrett
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Brott
mesh_terms: D020520:Brain Infarction / Q000188:drug therapy / Q000628:therapy*; D003131:Combined Modality Therapy; D057510:Endovascular Procedures / Q000379:methods*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006801:Humans; D016032:Randomized Controlled Trials as Topic; D015424:Reperfusion / Q000379:methods*; D010959:Tissue Plasminogen Activator / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator